• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

每日血液透析:最新进展

Daily hemodialysis: an update.

作者信息

Pierratos Andreas

机构信息

Humber River Regional Hospital, University of Toronto, Toronto, Ontario, Canada.

出版信息

Curr Opin Nephrol Hypertens. 2002 Mar;11(2):165-71. doi: 10.1097/00041552-200203000-00006.

DOI:10.1097/00041552-200203000-00006
PMID:11856908
Abstract

The interest in daily hemodialysis in the form of short daily hemodialysis and nocturnal hemodialysis has continued to increase over the past few years. A significant number of publications support the evidence for improved outcomes in most of the study areas, including financial benefits. The increased direct cost of the provision of daily hemodialysis seems to be the main obstacle to the wider acceptance of these methods. Convincing data of improved outcomes and evidence of cost efficiency of daily hemodialysis are being generated. These data may increase the interest of the institutional payors as well as of the dialysis industry to create the proper infrastructure for the use of daily hemodialysis. These dialysis regimens promise to have a major impact on the management of end-stage renal disease.

摘要

在过去几年中,人们对以短程每日血液透析和夜间血液透析形式进行的每日血液透析的兴趣持续增长。大量出版物支持了在大多数研究领域中改善治疗效果的证据,包括经济效益。提供每日血液透析增加的直接成本似乎是这些方法更广泛应用的主要障碍。目前正在产生关于每日血液透析改善治疗效果和成本效益的令人信服的数据。这些数据可能会增加机构付款人和透析行业对创建使用每日血液透析的适当基础设施的兴趣。这些透析方案有望对终末期肾病的管理产生重大影响。

相似文献

1
Daily hemodialysis: an update.每日血液透析:最新进展
Curr Opin Nephrol Hypertens. 2002 Mar;11(2):165-71. doi: 10.1097/00041552-200203000-00006.
2
More intensive hemodialysis.更强化的血液透析。
Clin J Am Soc Nephrol. 2009 Dec;4 Suppl 1:S121-4. doi: 10.2215/CJN.02920509.
3
New approaches to hemodialysis.血液透析的新方法。
Annu Rev Med. 2004;55:179-89. doi: 10.1146/annurev.med.55.091902.103801.
4
Daily hemodialysis 2006. State of the art.
Minerva Urol Nefrol. 2006 Jun;58(2):99-115.
5
Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease.夜间血液透析可提高终末期肾病高血压患者的动脉压力反射敏感性和顺应性,并使血压恢复正常。
Kidney Int. 2005 Jul;68(1):338-44. doi: 10.1111/j.1523-1755.2005.00411.x.
6
Economic evaluation of dialysis therapies.透析疗法的经济学评估。
Semin Nephrol. 2009 Sep;29(5):524-32. doi: 10.1016/j.semnephrol.2009.06.009.
7
[Daily/nocturnal hemodialysis: only for the happy few or a real alternative for many?].[每日/夜间血液透析:只为少数幸运者,还是众多患者的真正选择?]
G Ital Nefrol. 2008 Mar-Apr;25(2):192-202.
8
The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis.家庭夜间血液透析与传统中心血液透析的生活质量和成本效用
Kidney Int. 2003 Sep;64(3):1004-11. doi: 10.1046/j.1523-1755.2003.00157.x.
9
Effects of nocturnal hemodialysis on melatonin rhythm and sleep-wake behavior: an uncontrolled trial.夜间血液透析对褪黑素节律及睡眠-觉醒行为的影响:一项非对照试验。
Am J Kidney Dis. 2009 Apr;53(4):658-64. doi: 10.1053/j.ajkd.2008.08.006. Epub 2008 Oct 31.
10
Short daily and nocturnal hemodialysis: new therapies for a new century?每日短时和夜间血液透析:新世纪的新疗法?
Saudi J Kidney Dis Transpl. 2009 Jan;20(1):1-11.

引用本文的文献

1
The impact of hemodialysis on retinal and choroidal thickness in patients with chronic renal failure.血液透析对慢性肾衰竭患者视网膜和脉络膜厚度的影响。
Int Ophthalmol. 2021 May;41(5):1763-1771. doi: 10.1007/s10792-021-01735-y. Epub 2021 Mar 19.
2
Dialysis: Nocturnal hemodialysis--should we still provide this therapy?透析:夜间血液透析——我们仍应提供这种治疗吗?
Nat Rev Nephrol. 2011 Sep 20;7(11):611-2. doi: 10.1038/nrneph.2011.140.
3
Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis.万古霉素在短时间每日血液透析期间的药代动力学和药效学。
Clin J Am Soc Nephrol. 2010 Nov;5(11):1981-7. doi: 10.2215/CJN.03450410. Epub 2010 Jul 8.
4
Safety of new phosphate binders for chronic renal failure.新型磷酸盐结合剂用于慢性肾衰竭的安全性
Drug Saf. 2003;26(15):1093-115. doi: 10.2165/00002018-200326150-00003.